Stock News That Gives You an Edge

Follow us on X Follow us on X for real-time stock news alerts
Stock News S&P 500
Main Pages
Stock News
Articles for $MTVA
MetaVia Inc. Updates Corporate Presentation, Highlights Growth Opportunities in Cardiometabolic DiseasesMetaVia Inc. Reports Year-End 2025 Financial Results with Positive Phase 1 Data for DA-1726MetaVia Inc. Receives IRB Approval for Phase 1 Clinical Trial of DA-1726, a Dual Agonist for Obesity Treatment
Vanward Edge
57 West 57th Street
New York, NY 10019
United States

Contact
Sitemap

Disclaimer
Vanward Edge provides SEC filing analysis, market bulletins, and stock impact ratings for informational purposes only and nothing on this website is investment, legal, tax, or financial advice. See our full disclaimer.
Disclaimer
Privacy Policy
Cookie Policy
GDPR